Forma Therapeutics Holdings Inc
FMTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-42,588,000.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.21 |
| Beta | -0.95 |
| Outstanding Shares | 47,805,493 |
Return
| Return on Equity | -45.88% |
|---|---|
| Return on Assets | -40.02% |
| Return on Invested Capital | -42.84% |
Valuation & Multiples
| P/E Ratio | -4.75 |
|---|---|
| PEG | -23.04 |
| Price to Sales | - |
| Price to Book Ratio | 2.5 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.23 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.76 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Forma Therapeutics Holdings Inc
105 employeesForma Therapeutics is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. Its R&D engi...